|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||69.83 - 70.82|
|52 Week Range||52.51 - 80.71|
|PE Ratio (TTM)||33.36|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Here we discuss how Medical Outpatient and home healthcare continue to create opportunities for investors keen on parking their money in the healthcare space.
DaVita Inc (NYSE:DVA) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. With many analysts covering the large-cap stock, we mayRead More...
The firm was among several potential buyers including large retailers, strategic health-care partners and venture-capital and private equity firms.
NEA has acquired DaVita's primary care business, Paladina Health. The Silicon Valley venture fund with more than $3 million under management occasionally acquires majority positions in companies when it sees a big opportunity. New Enterprise Associates, the Silicon Valley venture firm with a massive $3 billion under management, has acquired DaVita' DVA s chain of primary care clinics, Paladina Health , for around $100 million.
With Morgan Stanley calling clinical laboratory services market a safe haven, let's find out what's working in favor and against this burgeoning niche market.
DaVita (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Davita's kidney care unit is gaining prominence worldwide. However, the company is grappling with labor-union woes in California and Ohio.
Let's put DaVita (DVA) stock into this equation and find out if it is a good choice for value-oriented investors right now.
DaVita (DVA) collaborates with Epic to introduce electronic health record facility for patients, reduce costs and enhance healthcare.
The Dow endured a volatile week even as Republicans tasted success on the tax legislation front.